Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Topical Tapinarof and Roflumilast for Psoriasis: Where Do they Fit In?
“They’re very fast-acting, effective,” and result in a large improvement over steroids, Dr. Jashin Wu said.
News
Topical Treatment Provides a Noninvasive Option for Pyogenic Granuloma in Children
Several case reports about the use of the topical form of timolol, a nonselective beta-adrenergic antagonist, for PG have been published.
News
Managing Vitiligo: Combination Therapies, New Treatments
The level of vitiligo disease activity drives medical management.
News
Focusing on Value in Social Media Posts
One review noted that social media ranks as the sixth top factor for a patient deciding whether to have a laser procedure.
News
Support for Laser Treatment to Reduce NMSC Risk is Increasing
There is a “growing body of research that demonstrates we are improving the health of our patients’ skin with certain types of laser treatments,...
News
Second Treatment for Prurigo Nodularis Approved by FDA
Nemolizumab is currently under FDA review for treating atopic dermatitis in...
News
Who’s Behind Cosmetic Procedures at MedSpas?
Researchers enlisted help from "secret shoppers" who contacted MedSpas to ask about the level of training, if patients underwent a review of...
News
Fillers, Hyaluronidase Relieve Orofacial Changes in Patients with Scleroderma
The recommended treatment for scleroderma patients was to use nerve blocks for injecting HA filler or hyaluronidase and to minimize the injection...
News
Nonmelanoma Skin Cancer: Encouraging Data on Laser Treatment
Data was strongest for the use of lasers for treating basal cell carcinoma, especially pulsed-dye lasers.
News
Skin Dxs in Children in Refugee Camps Include Fungal Infections, Leishmaniasis
In a study of 125 children at a Sierra Leone–based displacement camp, the prevalence of scabies was 77% among those aged < 5 years and 86%...
News
Advantages of a Pediatric Rheumatology/Dermatology Clinic Evaluated
The top four primary diagnoses at the clinic were linear morphea (33%), lupus (23%), ...
News
Underserved Families Share Ways to Improve Access to Pediatric Dermatologists
Barriers to receiving pediatric dermatology care included distrust of the healthcare system, distance to the hospital, and household income.
News
Study Finds Gout Drug Effective for Aphthous Ulcers in Children
“Complex aphthous stomatitis in children is typically treated with topical supportive care, which is often not effective,” one of the study...
News
Safety Standards a Top Priority for ASLMS President
“I am excited to see how artificial intelligence and robotics play a role in energy-based devices,” Arisa E. Ortiz, MD, said in a Q&A with...
News
FDA Approves Deuruxolitinib for Severe Alopecia Areata in Adults
Deuruxolitinib, which comes in 8-mg tablets, is an oral selective inhibitor of JAK1 and JAK2 and is administered twice a day.